{"id":2691,"date":"2014-12-03T16:31:17","date_gmt":"2014-12-03T15:31:17","guid":{"rendered":"https:\/\/www.farmaindustria.es\/web_en\/?p=2691"},"modified":"2014-12-03T16:31:17","modified_gmt":"2014-12-03T15:31:17","slug":"innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines","status":"publish","type":"post","link":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/","title":{"rendered":"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines"},"content":{"rendered":"

Madrid, December 3rd 2014<\/strong>.-Innovation and commitment to society and citizens\u2019 health are two of the pharmaceutical industry\u2019s strategic lines, as was confirmed today by Humberto Arn\u00e9s, director general of FARMAINDUSTRIA during the opening session of the 2nd We are Patients forum, organized by \u201cSomos Pacientes\u201d.\u00a0 This We are Patients is an online community, fostered by the Association which brought together more than 1400 entities and organizations today.<\/p>\n

During his intervention, which focused on patient access to innovations, not just relative to therapeutics but also technology and information, Arn\u00e9s stressed that innovation is \u201cin the DNA\u201d of the pharmaceutical sector. \u201cThe companies\u2019 activities are centred mainly on the development of new molecules which are ultimately used to eradicate several diseases or, at least, improve the quality of life of those who are suffering them\u201d.<\/p>\n

Arn\u00e9s reminded us that the pharmaceutical industry is the sole collective body capable of organizing economical, technical and human resources on a large scale in order to research one single medicine; this requires an investment of more than 1,000 million euro, over a timeframe of ten years with the participation of an enormous multi-disciplinary team\u201d.<\/p>\n

Imaginative formulas<\/strong><\/p>\n

Faced with the current situation whereby public administrations have limited resources and the imminent arrival of new breakthrough medicines, farmaindustria\u2019s director general explained that \u201cthe solution lies in the agreement of the different stakeholders, so that with each contribution, we will be able to search for imaginative formulas which will make it possible for our healthcare system to incorporate the most avant-garde therapies, guaranteeing patient access to the same conditions of equity, equality and quality, plus adequately rewarding innovation so that the pharmaceutical \u00a0R&D cycle, hence progress, is not detained\u201d.<\/p>\n

Likewise, he highlighted the role of patients in this process. \u201cThe new concept of informed patients, aware of their disease and of the treatments available -and of those treatments that are in the pipeline- \u00a0will have an outstanding position in the design and implementation of new clinical trials, in the ethics committee debates, or in the elaboration of therapeutic position reports, which will be key for the authorization and reimbursement of medicines on the public administration\u2019s side\u201d.<\/p>\n

In this regard, Humberto Arn\u00e9s was fully convinced that healthcare and all of its agents should continue to focus in search of benefits for patients, but at the same time, counting on their opinion and participation in the processes of clinical and social care at all times. \u201cPatients and their relatives should be found at the centre of the system, and every activity should be oriented, taking into account their interests and needs\u201d, he stated.<\/p>\n

Finally he remarked about the importance information holds in this new role -which patients will surely take on- and how new technology and communication tools are empowering them, allowing them to become a much more active participant in the system, \u201cformulating a perfectly armed speech and raising their voices so that their interests, concerns and need are heard loud and clear by members of the Government, Autonomous Regions, healthcare professionals, pharmaceutical companies and other private and public stakeholders\u201d.<\/p>\n

This 2nd We are Patients Forum brought together more than a hundred attendees, including researchers, members of patients\u2019 associations, healthcare professionals, public administration spokespersons and representatives of the pharmaceutical industry.<\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Madrid, December 3rd 2014.-Innovation and commitment to society and citizens\u2019 health are two of the pharmaceutical industry\u2019s strategic lines, as was confirmed today by Humberto Arn\u00e9s, director general of FARMAINDUSTRIA during the opening session of the 2nd We are Patients forum, organized by \u201cSomos Pacientes\u201d.\u00a0 This We are Patients is an online community, fostered by …<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2691","post","type-post","status-publish","format-standard","hentry","tema-ensayos-clinicos","tema-pacientes","tema-precios","tema-regions","tema-investigacion-y-desarrollo"],"acf":[],"yoast_head":"\nInnovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines - FarmaIndustria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines - FarmaIndustria\" \/>\n<meta property=\"og:description\" content=\"Madrid, December 3rd 2014.-Innovation and commitment to society and citizens\u2019 health are two of the pharmaceutical industry\u2019s strategic lines, as was confirmed today by Humberto Arn\u00e9s, director general of FARMAINDUSTRIA during the opening session of the 2nd We are Patients forum, organized by \u201cSomos Pacientes\u201d.\u00a0 This We are Patients is an online community, fostered by …\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/\" \/>\n<meta property=\"og:site_name\" content=\"FarmaIndustria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl\" \/>\n<meta property=\"article:published_time\" content=\"2014-12-03T15:31:17+00:00\" \/>\n<meta name=\"author\" content=\"Nathalie Rooney\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:site\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nathalie Rooney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/\"},\"author\":{\"name\":\"Nathalie Rooney\",\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/#\\\/schema\\\/person\\\/0d4299f2aea1d36b54db40fc10230603\"},\"headline\":\"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines\",\"datePublished\":\"2014-12-03T15:31:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/\"},\"wordCount\":563,\"commentCount\":0,\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/\",\"url\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/\",\"name\":\"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines - FarmaIndustria\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/#website\"},\"datePublished\":\"2014-12-03T15:31:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/#\\\/schema\\\/person\\\/0d4299f2aea1d36b54db40fc10230603\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/2014\\\/12\\\/03\\\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/#website\",\"url\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/\",\"name\":\"FarmaIndustria\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/#\\\/schema\\\/person\\\/0d4299f2aea1d36b54db40fc10230603\",\"name\":\"Nathalie Rooney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g\",\"caption\":\"Nathalie Rooney\"},\"url\":\"https:\\\/\\\/www.farmaindustria.es\\\/web_en\\\/documents\\\/press-releases\\\/author\\\/franfranco\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines - FarmaIndustria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/","og_locale":"en_US","og_type":"article","og_title":"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines - FarmaIndustria","og_description":"Madrid, December 3rd 2014.-Innovation and commitment to society and citizens\u2019 health are two of the pharmaceutical industry\u2019s strategic lines, as was confirmed today by Humberto Arn\u00e9s, director general of FARMAINDUSTRIA during the opening session of the 2nd We are Patients forum, organized by \u201cSomos Pacientes\u201d.\u00a0 This We are Patients is an online community, fostered by …","og_url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/","og_site_name":"FarmaIndustria","article_publisher":"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl","article_published_time":"2014-12-03T15:31:17+00:00","author":"Nathalie Rooney","twitter_card":"summary_large_image","twitter_creator":"@FarmaIndustria","twitter_site":"@FarmaIndustria","twitter_misc":{"Written by":"Nathalie Rooney","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/#article","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/"},"author":{"name":"Nathalie Rooney","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"headline":"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines","datePublished":"2014-12-03T15:31:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/"},"wordCount":563,"commentCount":0,"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/","url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/","name":"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines - FarmaIndustria","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#website"},"datePublished":"2014-12-03T15:31:17+00:00","author":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603"},"breadcrumb":{"@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/2014\/12\/03\/innovation-commitment-society-patients-pharmaceutical-industrys-strategic-lines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.farmaindustria.es\/web_en\/"},{"@type":"ListItem","position":2,"name":"Innovation and commitment to Society and Patients are the pharmaceutical industry\u2019s strategic lines"}]},{"@type":"WebSite","@id":"https:\/\/www.farmaindustria.es\/web_en\/#website","url":"https:\/\/www.farmaindustria.es\/web_en\/","name":"FarmaIndustria","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.farmaindustria.es\/web_en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.farmaindustria.es\/web_en\/#\/schema\/person\/0d4299f2aea1d36b54db40fc10230603","name":"Nathalie Rooney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a544889d96ab667147c2dddf3cdd9b4cdf2a0044511df45b193d666e09d8b3db?s=96&d=mm&r=g","caption":"Nathalie Rooney"},"url":"https:\/\/www.farmaindustria.es\/web_en\/documents\/press-releases\/author\/franfranco\/"}]}},"_links":{"self":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/comments?post=2691"}],"version-history":[{"count":1,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2691\/revisions"}],"predecessor-version":[{"id":2692,"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/posts\/2691\/revisions\/2692"}],"wp:attachment":[{"href":"https:\/\/www.farmaindustria.es\/web_en\/wp-json\/wp\/v2\/media?parent=2691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}